Comments
The rights issue of Brooks Laboratories opens for subscription on Wednesday. It plans to issue up to 76.66 lakh equity shares of face value ₹10 each for cash at a price of ₹20 a share for an amount aggregating up to ₹15.33 crore on rights basis.
The rights entitlement ratio has been fixed at nine rights equity shares for every 20 fully paid-up equity shares held by the equity shareholders on the record date, i.e. February 12. Shareholders and investors would watch the response to the rights issue.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.